Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).
      Description

      A phase 1, open-label safety, tolerability and early efficacy study of a Renal Autologous Cell Therapy (REACT) in patients with Chronic Kidney Disease from Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) (REGEN-004)

      Conditions
      Chronic Kidney DiseaseCongenital Anomalies of Kidney and Urinary Tract
      Talk to us
      TERMINATED
      A Study of Participants With Chronic Kidney Disease Previously Treated With REACT
      Description

      The purpose of this study is to evaluate the safety of supplemental REACT injections in participants with chronic kidney disease (CKD) who have previously received REACT treatment.

      Conditions
      Diabetic Kidney DiseaseCAKUTChronic Kidney Diseases
      Talk to us